Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00341055
Status:
COMPLETED
Last Update Posted:
2011-06-10
First Post:
2006-06-19
Brief Title:
A Study to Evaluate the Hematologic Response Rate the Rate at Which the Hemoglobin Level Rises of PROCRIT Epoetin Alfa Given at a Dose of 80000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Organization Data
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Class:
INDUSTRY
Study ID:
CR005110
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ortho Biotech Products LP | INDUSTRY |